Search review questions

Work status Not reported · people with low back pain

Any outcome considered an indicator of change · mass media intervention for promoting healthy behaviours

Any measure of knowledge and attitude · adult, ethnic minority group: self‐described Americans of African heritage

Adverse effects · adult, ethnic minority group: self‐described Americans of African heritage

Any outcome considered an adverse effect · adult, ethnic minority group: self‐described Americans of African heritage

Adverse effects · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African…

Any outcome considered an adverse effect · adult, ethnic minority groups: Latino immigrants, elderly Chinese immigrants, self‐described Americans of African…

Adverse effects · mass media intervention for promoting healthy behaviours

Any outcome considered an adverse effect · mass media intervention for promoting healthy behaviours

Incidence of acute exacerbations of bronchiectasis ‐ not reported · people with bronchiectasis

Duration of acute exacerbation of bronchiectasis ‐ not reported · people with bronchiectasis

Incidence of hospitalisation ‐ not reported · people with bronchiectasis

Engagement with services: clinically important change in engagement with services, as defined by individual studies · people with schizophrenia and their carers

Treatment adherence: clinically important change in treatment adherence, as defined by individual studies · people with schizophrenia and their carers

Understanding: clinically important change in understanding the nature of illness and its outcome, as defined by individual studies · people with schizophrenia and their carers

Quality of life: clinically important change in general quality of life or well‐being, as defined by individual studies · people with schizophrenia and their carers

Mental state: clinically important change in mental state, as defined by individual studies · people with schizophrenia and their carers

Satisfaction communication of diagnosis: clinically important change (patient or carer's), as defined by individual studies · people with schizophrenia and their carers

Adverse effect: clinically important adverse effect of intervention ‐ as defined by individual studies · people with schizophrenia and their carers

Cardiovascular mortality ‐ not reported · patients with stable angina pectoris

Non‐cardiovascular mortality ‐ not reported · patients with stable angina pectoris

Non‐cardiovascular mortality ‐ not reported · patients with stable angina pectoris

Physical function · individuals with fibromyalgia

Pain intensity · individuals with fibromyalgia

Fatigue · individuals with fibromyalgia

Stiffness · individuals with fibromyalgia

Physical function · individuals with fibromyalgia

Child adverse effect: hyperthyroidism · women during the preconception, pregnancy and postpartum period

Incidence of serious adverse events (we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) · peripheral nerve block

Incidence of serious adverse events (we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) · participants undergoing surgery with peripheral nerve block

Heparin‐induced thrombocytopenia ‐ not reported · people > 18 years of age with a diagnosed deep vein thrombosis

Major bleeding during the initial treatment · people > 18 years of age with a diagnosed deep vein thrombosis

All‐cause mortality · people > 18 years of age with a diagnosed deep vein thrombosis

Heparin‐induced thrombocytopenia · people > 18 years of age with a diagnosed deep vein thrombosis

All harmful effects · people > 18 years of age with a diagnosed deep vein thrombosis

Major bleeding during the initial treatment · people > 18 years of age with a diagnosed deep vein thrombosis

Heparin‐induced thrombocytopenia · people > 18 years of age with a diagnosed deep vein thrombosis

Heparin‐induced thrombocytopenia ‐ not measured · people > 18 years of age with a diagnosed deep vein thrombosis

Major bleeding during the initial treatment ‐ not reported · people > 18 years of age with a diagnosed deep vein thrombosis

Gestational age of the infant · neonates requiring endotracheal intubation

Level of experience of the intubator · neonates requiring endotracheal intubation

Type of stylet · neonates requiring endotracheal intubation

Steroid‐related AEs ‐ not reported · adults with asthma

Exacerbations requiring hospitalisation ‐ not reported · adults with asthma

Global state: clinically important change · people with schizophrenia

Adverse effects: clinically significant extrapyramidal symptoms · people with schizophrenia

Cost of care · people with schizophrenia

Adverse events · people with burns

Infection · people with burns

Infection · people with burns